Megakaryoblastic differentiation in MPN-BP represents up to 25% of cases: its recognition can be challenging since megakaryoblasts are mostly negative for CD34 and are often hardly distinguishable from dysplastic megakaryocytes. The gene discussed is CD34; the disease is myeloproliferative disorder.